Warren Nachlis

Intellectual Property; Technology; Health Care & Life Sciences

WWarren Nachlis is a seasoned IP strategist who has guided leading life science and technology operating companies, investors and research institutions through the most complex licensing and technology transactions worldwide. Drawing on more than two decades of experience structuring and diligencing billions of dollars in pharmaceutical, biotechnology, medical device and technology deals, he delivers clear, practical assessments that let C-suite decision makers quantify risk, accelerate timelines and preserve optionality. Warren regularly designs and negotiates mission-critical agreements, including cross-border collaboration agreements and licenses, joint ventures, sponsored research arrangements, and development and supply contracts. He is equally fluent in the IP dimensions of mergers, acquisitions, capital markets offerings, secured lending, asset securitizations and private equity investments, enabling seamless alignment between legal exposure and financial modeling. Warren offers a rigorous, commercially attuned perspective designed to maximize enterprise value.